July 06, 2020: Global Response Aid (GRA), an affiliate of Agility, and Dr. Reddy’s Laboratories have signed a deal with FujiFilm for global production and distribution of the anti-viral drug favipiravir being tested in several countries as a potential treatment for Covid-19, under the brand name Avigan.
Role of Agility & Dr. Reddy’s
The agreement calls for GRA and Dr. Reddy’s to manage sales, marketing, regulatory compliance and distribution of Avigan. As an affiliate of Agility, GRA will use the logistics company’s global network. Agility has more than 30 GDP-certified facilities worldwide and will provide a full range of logistics services: storage, distribution and transportation to include air freight, ocean freight and road freight. Dr. Reddy’s will manufacture the Active Ingredient and Formulation of Avigan, utilizing its multiple manufacturing facilities in different locations.
Markets home to 6 billion people
The partnership will eventually cover manufacturing and distribution for markets that are home to 6 billion of the world’s 7.8 billion people. FujiFilm will continue to market Avigan exclusively in Japan, Russia and China. Dr. Reddy’s and GRA will distribute, sell and market Avigan in all other countries globally.
Source: Agility
